Diclofenac impairs the proliferation and glucose metabolism of triple‑negative breast cancer cells by targeting the c‑Myc pathway

Lihui Yang(Guangxi Medical University), Xiaodong Zhang(Guangxi Medical University)
Experimental and Therapeutic Medicine
April 2, 2021
Cited by 37


Related Papers